"Tontine" Health Insurance: A Misdiagnosis

Two law school professors advocate Tontine Heath Insurance plans in today’s New York Times.   These plans would pay a “dividend” if patients did not use non-preventive services over a five year period, and Baker and Siegelman suggest that this would help overcome the resistance that “young invincibles” have to making a “bad investment” in health insurance.   

 

I think the authors have misdiagnosed the problem.  Perhaps some young adults don’t purchase insurance because they feel it’s a bad investment; more don’t purchase insurance because it is just too expensive and they have competing financial needs.  Reserving dollars to pay dividends to policy-holders who had no claims would make insurance even more expensive, unless you believe that the potential of a dividend would bring in massive numbers of beneficiaries with few or no expenses, or  would convince policy-holders to forego discretionary treatment. 

 

Remember that among all adults 19-64, the 50% of patients with the lowest medical bills represent only 3% of all medical costs, so there just aren’t a lot of savings to be had amongst the healthy beneficiaries.  On the other hand, the 10% of patients with the highest bills represent over 2/3 of all medical expenses, and the Tontine scheme would not do anything to lower costs of this population.   I believe that this asymmetry of spending is even more extreme in the 19-29 year old group than in all adults.

 

In this era of plummeting 401Ks, the young (or others) should not be looking to health insurance as an investment vehicle. In fact, as the life insurance market has shown us, it’s better to separate the core insurance function from an investment vehicle. That’s why term life insurance products are more prudent and have become vastly more common than “whole” life policies that couple life insurance with an investment.

 

Health insurance, for the young and for most others, should be a bad investment unless you are unlucky enough to have a significant illness.  The social pooling function of health insurance dictates that the premium dollars of the healthy will pay for the costs of caring for the sick.

Silver Lining

There is a lot of sniping at Massachusetts’ health care reform. The fact that the sniping comes from both the right and the left probably means that we’ve done something right in our state, although the combination of continuing health care inflation and the declining economy will make it hard to sustain the increased rate of coverage of Massachusetts residents. In this post, I’ll review some of the critiques of the Massachusetts plan, and offer some optimistic musings about how the “Great Recession” could make it easier to make health care affordable.

This weekend, the Boston Globe offered an op-ed by Susanne King, a western Massachusetts psychiatrist who complained that health care reform failed to meet five critical tests posed by the Institute of Medicine. She noted that health coverage in Massachusetts is

- - Not universal (but we’ve cut the uninsured rate by more than half)

- - Still tied to employment (not clear where the money will come from if employers are out of the picture),

- - Not affordable for patients (admittedly, we have a long way to go – but reform of the individual market is real progress here)

- - Not affordable by society (I agree with the author here)

- - Doesn’t guarantee access (But it takes years or decades to train additional physicians in fields like psychiatry and primary care, and our problems in Massachusetts are not worse than those elsewhere in the country).

On the right, the National Center For Policy Analysis continues its tirade against the Massachusetts law –and ironically cites researchers including Steffie Woolhandler and David Himmelstein, ardent supporters of a single payer system. The complaints from the right and left are eerily similar.

For Massachusetts’ health care reform to be sustainable, the overall rate of medical inflation must come down considerably. I’ve pointed out before that all that medical inflation is someone’s income; therefore, doctors, hospitals, pharmaceutical companies, and others will fight aggressively to avoid losing income. That’s why despite real efforts at reform we usually end up with the status quo.

On the optimistic side, here are some reasons why this might not be as hard as we’ve all been worrying to lower health care inflation. I know that the “Great Recession” has already led to very significant pain and financial and personal losses; I also believe that it will offer a chance to lower medical inflation. Talk about a silver lining!

1) Volume Decreases in Medical Care:

- Informally, my colleagues say that they have seen dramatic declines in elective diagnostic and therapeutic procedures and hospitalizations, though Thompson Reuters doesn't see things as quite so dire. These declines will lead to lower overall medical costs. I wouldn’t be surprised to see some health plans reporting outsized earnings on insured business, too, because actuaries had counted on higher utilization.

- Americans are not only having second thoughts about buying a new car – they’re also thinking twice about their copayments for medications and for office visits. The increased consumer copayments and deductibles will lead to more self-editing of care in 2009 than it did in past years as our perception of wealth declines precipitously. Since most medical interventions are NOT cost saving, foregone medical care will general result in health care savings, although it might also lead to worse clinical outcomes.

- Decreased medical procedures could also lead to increased surplus capacity in the medical system, which is likely to lead to decreased prices

2) Sin Taxes

The Congressional Budget Office doesn’t think that raising taxes on tobacco or on sweetened drinks will decrease the federal budget deficit – but I think that this will have a measurable impact on the total cost of medical care. Tobacco taxes are on the way up, and the relationship between tobacco cost and initiating smoking is irrefutable. A recent study in Colorado Springs showed that acute myocardial infarction in the community went down in just a single year after an indoor tobacco ban. Now that’s medical cost savings! Although I don’t know of a study that shows that raising the price of soda lowers use, I do know that the relative decrease in the price of soda over my lifetime is strongly associated with increased use of corn-syrup sweetened beverages. . We don’t have a great medical answer for obesity besides for bariatric surgery, so any public health approach to decrease caloric intake is welcome.

3) Evidence Based Medicine

- This will take longer, but investing $1.1 billion of the stimulus on effectiveness research could have a substantial impact on medical costs. New drugs and devices are priced based on perceived value, so explicit studies of comparative effectiveness might lower asking prices even before the studies are complete. This is because manufacturers will want positive results from comparative effectiveness studies, and positive results are more likely with lower prices.

4) Decreased Expectation of Fee for Service Revenue

- Many commentators have pointed out that paying fee for service leads to higher utilization, but the health care delivery system is not optimized to pay for meaningful bundles or capitation at this point. The deflationary pressure on prices in general could make fee for service less attractive, which could lead to better opportunities to bundle payments. Of course, much of the delivery system is not at this point especially well positioned to accept capitation or bundled payments.



The Future of Health Plans

It’s been a bad week for health insurers – most of them lost substantial value in the stock market this week after the Obama budget was released, causing investor worry due to lower payments to Medicare HMOs.  Further, the economic funk and rising unemployment will lead to a decrease in the number of Americans insured through the private marketplace, and continuing “buy downs” from comprehensive coverage to policies with higher deductibles and copays.  These plans are also far less profitable to the insurers.

 

Perhaps the biggest threat to health insurers is the possibility that health care reform could allow those under 65 without disabilities to “buy into” Medicare.   Proponents argue that Medicare has low transactional costs, obtains high levels of provider discounts and offers excellent choice to its patients.  How does Medicare achieve these economies?

(1)Medicare spends less than commercial health plans on administration as a percentage of premium – in part because it need do no marketing to attract enrollees, and in part because the premiums are so much higher for the Medicare population than they are for those under 65 (so administration costs shrink as a percentage of total costs.)

(2)Medicare does not do “network contracting” as private health plans do.  All licensed physicians who have not been convicted of fraud are eligible to join – and to do so they must agree to follow a uniform set of Medicare rules and to accept Medicare reimbursement rates. 

(3)Hospitals have long collected data showing that they lose money on Medicare, and make this up by obtaining high rates from commercial insurance plans.  It’s a classic example of cost-shifting.  If the commercial plans didn’t exist, we would either have to take billions out of our inpatient facilities, or Medicare would have to pay substantially higher rates.  

 

Today’s NY Times has an article by Reed Abelsonon how health insurers are positioning themselves for health care reform. The article contrasts the approach of United Health Care, which boasts of diversifying its business, with Aetna, which promotes itself as a company that can actually influence the delivery of health care.

 

Without diversifying out of health insurance, how can health plans add value and continue to prosper in the coming years?

 

(1)Empower patients

Engaged patients who know about their illnesses and their medical care have better outcomes, and sometimes they even prevent medical errors.  Health plans are excellent at marketing, and know how to get the attention of their enrollees.

(2)Convert vast quantities of data into information to transform health care

Some commentators decry the inaccuracy and lack of timeliness of claims data.  But my experience is that claims information is very complete, since few providers fail to bill for their services. Unfortunately, electronic medical record data tends to be unstructured and is documented differently from system to system.

(3)Promote innovative payment methodologies for providers

The current predominately fee for service reimbursement encourages additional units of service, and does not encourage coordination of care.   Medicare is statutorily mandated to pay fee-for-service, and based on its size alone would have a hard time moving ambulatory care into episode based payment or capitation.  Health plans have to compete with each other for patients and for provider networks, and the existence of multiple competing insurers makes it more likely we will see innovation in payment methodology.  

(4)Develop selective networks

Medicare is too big to develop exclusive networks, and the political fallout from excluding a major hospital or a large group of physicians from Medicare would be huge.  Health insurers can develop selective networks for a broad range of patients, or can develop selective networks for narrow groups such as patients who require organ transplantation or inpatient behavioral health care.   Multiple competing insurers are key to this type of innovation.

(5)Transparency

Medicare made some substantial strides in promoting transparency over the last few years   But health plans have put dramatically more information on the web about provider quality.  Health plans should make their data available to state agencies or collaborative to do reporting, and should continue their efforts to educate their members about where to get the highest quality, cost-effective care.

(6)Promote evidence-based care

We have adequate evidence of the efficacy of too few medical decisions. But even where the evidence is in, our health care system remains unreliable.  We treat few diabetics to blood pressure, blood sugar, and cholesterol goal, and we send patients out of our offices with blood pressure which is often too high.  We miss vaccinations and cancer screenings. We give patients medications that are dangerous in combination, and medicines that are dangerous in the context of an individual patient’s coexisting medical illnesses.   Health plans should use claims and other data to identify opportunities to improve care for individuals and populations, and implement programs to alert providers and patients to opportunities to deliver better health care.

 

 

Health care reform will mean enormous changes – and much disruption in the health insurance market.  There will be plenty of opportunities for innovative health plans to add value and use their expertise to improve the quality and the cost-effectiveness of care.